Abstract
Fluvoxamine and imipramine were compared to placebo in an 8-week doubleblind randomized multicentre trial comprising of 148 outpatients between 19 and 57 years of age (mean: 35) with a DSM-III-R diagnosis of Panic Disorder. mean daily dose at endpoint was: fluvoxamine, 171.4 mg; imipramine 164.7 mg. The mean number of panic attacks per week at baseline were 10.9, 14.4 and 6.5 for fluvoxamine, imipramine and placebo, respectively. The intent-to-treat analysis of the change from baseline (difference score) of the number of panic attacks at endpoint revealed: a difference of 3.3 attacks (95% CI: -0.3, 6.8) between fluvoxamine and placebo and a difference of 6.0 attacks (95% CI: 1.5, 10.5) between imipramine and placebo. Treatment was stopped prematurely in 31 (62%) on fluvoxamine, 16 (33%) on imipramine and 29 (58%) on placebo. The number of patients withdrawing due to intolerance was 13 (26%) for fluvoxamine, 10 (21%) for imipramine and 4 (8%) for placebo. The number of patients withdrawing due to lack of efficacy was 10 (20%) for fluvoxamine, 4 (8%) for imipramine and 12 (24%) for placebo. Overall, this study demonstrated that fluvoxamine was not effective in the treatment of panic disorder but did show a strong effect for imipr...Continue Reading
Citations
Nov 29, 2002·Human Psychopharmacology·Michel Bourin, Olivier Lambert
Nov 10, 1998·Biological Psychiatry·J M KentJ M Gorman
Mar 4, 1998·Journal of Psychosomatic Research·J T Apter
Jul 27, 2001·Psychiatry Research·G M AsnisS W Woods
Sep 5, 2001·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·S Kasper, E Resinger
Aug 19, 2007·CNS Drugs·Giulio PerugiCristina Toni
Aug 29, 2002·Acta Psychiatrica Scandinavica·A BakkerP Spinhoven
Jul 29, 2010·Expert Review of Neurotherapeutics·Marina Dyskant Mochcovitch, Antonio Egidio Nardi
Mar 3, 2015·Expert Opinion on Drug Metabolism & Toxicology·Alfredo Carlo AltamuraMassimiliano Buoli
Oct 25, 2008·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Borwin BandelowJohann Vega
Jun 9, 2015·Pharmacology, Biochemistry, and Behavior·M ErburuR M Tordera
Oct 6, 2015·Depression and Anxiety·Bret R RutherfordSteven P Roose
Jun 3, 2017·PloS One·Irene BighelliCorrado Barbui
Apr 6, 2018·The Cochrane Database of Systematic Reviews·Irene BighelliCorrado Barbui
Sep 13, 2016·The Cochrane Database of Systematic Reviews·Irene BighelliCorrado Barbui
May 15, 2002·Journal of Clinical Psychopharmacology·Giampaolo PernaLaura Bellodi
May 10, 2021·Asian Journal of Psychiatry·Yang DuLizhi Chen